Matthew Kaczynski

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Karla P. Zepeda, Christina C. Chang, Kamil H A Kim, 2022, Annals of Internal Medicine.

80% of patients with COVID-19 have ≥1 long-term effect at 14 to 110 d after initial symptoms

E. Mylonakis, Matthew Kaczynski, 2022, Annals of Internal Medicine.

A Pilot Trial of Thymalfasin (Tα1) to Treat Hospitalized Patients with Hypoxemia and Lymphocytopenia due to COVID-19 Infection

E. Mylonakis, E. Mylona, Gregorio Benitez, 2022, The Journal of infectious diseases.

Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers

E. Mylonakis, A. Balazs, C. King, 2023, Vaccine.

Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers

E. Mylonakis, A. Balazs, C. King, 2023, Vaccine.

Factors Associated With Enrollment into Inpatient Coronavirus Disease 2019 Randomized Controlled Trials: A Cross-sectional Analysis

E. Mylonakis, S. Kalagara, E. Mylona, 2023, Open forum infectious diseases.

Clinical Outcomes of Adult Patients Hospitalized with COVID-19 after Vaccination

E. Mylonakis, S. Kalagara, E. Mylona, 2021, Tropical medicine and infectious disease.

Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers

E. Mylonakis, A. Balazs, C. King, 2023, Vaccine.

Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19

E. Mylonakis, E. Mylona, Gregorio Benitez, 2023, International Immunopharmacology.

Clinical Outcomes Associated with SARS-CoV-2 Co-Infection with Rhinovirus and Adenovirus in Adults—A Retrospective Matched Cohort Study

E. Mylonakis, Gregorio Benitez, F. Shehadeh, 2022, International journal of environmental research and public health.